カテゴリー： 世界, 医療/バイオ, LP Information

世界のTEN治療市場予測 2023年-2029年

【英語タイトル】Global TEN Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC09600）・商品コード：LP23DC09600
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：118
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のTEN治療市場」は、過去の販売実績から2022年の世界のTEN治療の総販売量を検討し、2023年から2029年の予測されるTEN治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のTEN治療の市場規模を掲載し、XXX百万米ドル規模の世界のTEN治療市場の詳細な分析を提供します。本インサイトレポートは、世界のTEN治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のTEN治療市場における各社の独自のポジションをより深く理解するために、TEN治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のTEN治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。TEN治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。TEN治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。TEN治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

TEN治療の世界主要メーカーとしては、3M、 Cardinal Health、 BD、 Smith + Nephew、 Novartis AG、 Amneal Pharmaceuticals LLC.、 Amgen Inc.、 Pfizer Inc.、 Colgate-Palmolive Company、 Merck & Co., Inc.、 Molnlycke HealthCare AB.、 Xttrium Laboratories、 Schulke & Mayr GmbH、 ICPA Health Products Ltd、 Purdue Pharma L.P.、 eugia (Subsidiary of Aurobindo Pharma)、 AdvaCare Pharmaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のTEN治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではTEN治療市場をセグメンテーションし、種類別 (経口、外用、その他)、用途別 (子供、大人)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口、外用、その他

・用途別区分：子供、大人

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のTEN治療市場の10年間の市場状況・展望は？
・世界および地域別に見たTEN治療市場成長の要因は何か？
・TEN治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・TEN治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：TEN治療の年間販売量2018-2029、地域別現状・将来分析
・TEN治療の種類別セグメント：経口、外用、その他
・TEN治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・TEN治療の用途別セグメント：子供、大人
・TEN治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のTEN治療市場
・企業別のグローバルTEN治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別のTEN治療の年間売上：2018-2023年の売上、市場シェア
・企業別のTEN治療販売価格
・主要企業のTEN治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

TEN治療の地域別レビュー
・地域別のTEN治療市場規模2018-2023：年間販売量、売上
・主要国別のTEN治療市場規模2018-2023：年間販売量、売上
・南北アメリカのTEN治療販売の成長
・アジア太平洋のTEN治療販売の成長
・ヨーロッパのTEN治療販売の成長
・中東・アフリカのTEN治療販売の成長

南北アメリカ市場
・南北アメリカの国別のTEN治療販売量、売上（2018-2023）
・南北アメリカのTEN治療の種類別販売量
・南北アメリカのTEN治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のTEN治療販売量、売上（2018-2023）
・アジア太平洋のTEN治療の種類別販売量
・アジア太平洋のTEN治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のTEN治療販売量、売上（2018-2023）
・ヨーロッパのTEN治療の種類別販売量
・ヨーロッパのTEN治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のTEN治療販売量、売上（2018-2023）
・中東・アフリカのTEN治療の種類別販売量
・中東・アフリカのTEN治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・TEN治療の製造コスト構造分析
・TEN治療の製造プロセス分析
・TEN治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・TEN治療の主要なグローバル販売業者
・TEN治療の主要なグローバル顧客

地域別のTEN治療市場予測レビュー
・地域別のTEN治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・TEN治療の種類別市場規模予測
・TEN治療の用途別市場規模予測

主要企業分析
3M、 Cardinal Health、 BD、 Smith + Nephew、 Novartis AG、 Amneal Pharmaceuticals LLC.、 Amgen Inc.、 Pfizer Inc.、 Colgate-Palmolive Company、 Merck & Co., Inc.、 Molnlycke HealthCare AB.、 Xttrium Laboratories、 Schulke & Mayr GmbH、 ICPA Health Products Ltd、 Purdue Pharma L.P.、 eugia (Subsidiary of Aurobindo Pharma)、 AdvaCare Pharma
・企業情報
・TEN治療製品
・TEN治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global TEN Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for TEN Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for TEN Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for TEN Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key TEN Treatment players cover 3M, Cardinal Health, BD, Smith + Nephew, Novartis AG, Amneal Pharmaceuticals LLC., Amgen Inc., Pfizer Inc. and Colgate-Palmolive Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “TEN Treatment Industry Forecast” looks at past sales and reviews total world TEN Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected TEN Treatment sales for 2023 through 2029. With TEN Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TEN Treatment industry.
This Insight Report provides a comprehensive analysis of the global TEN Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on TEN Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TEN Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TEN Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TEN Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of TEN Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral Type
External Type
Other
Segmentation by application
Child
Aldult
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
3M
Cardinal Health
BD
Smith + Nephew
Novartis AG
Amneal Pharmaceuticals LLC.
Amgen Inc.
Pfizer Inc.
Colgate-Palmolive Company
Merck & Co., Inc.
Molnlycke HealthCare AB.
Xttrium Laboratories
Schulke & Mayr GmbH
ICPA Health Products Ltd
Purdue Pharma L.P.
eugia (Subsidiary of Aurobindo Pharma)
AdvaCare Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global TEN Treatment market?
What factors are driving TEN Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do TEN Treatment market opportunities vary by end market size?
How does TEN Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global TEN Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for TEN Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for TEN Treatment by Country/Region, 2018, 2022 & 2029
2.2 TEN Treatment Segment by Type
2.2.1 Oral Type
2.2.2 External Type
2.2.3 Other
2.3 TEN Treatment Sales by Type
2.3.1 Global TEN Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global TEN Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global TEN Treatment Sale Price by Type (2018-2023)
2.4 TEN Treatment Segment by Application
2.4.1 Child
2.4.2 Aldult
2.5 TEN Treatment Sales by Application
2.5.1 Global TEN Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global TEN Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global TEN Treatment Sale Price by Application (2018-2023)
3 Global TEN Treatment by Company
3.1 Global TEN Treatment Breakdown Data by Company
3.1.1 Global TEN Treatment Annual Sales by Company (2018-2023)
3.1.2 Global TEN Treatment Sales Market Share by Company (2018-2023)
3.2 Global TEN Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global TEN Treatment Revenue by Company (2018-2023)
3.2.2 Global TEN Treatment Revenue Market Share by Company (2018-2023)
3.3 Global TEN Treatment Sale Price by Company
3.4 Key Manufacturers TEN Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers TEN Treatment Product Location Distribution
3.4.2 Players TEN Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for TEN Treatment by Geographic Region
4.1 World Historic TEN Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global TEN Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global TEN Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic TEN Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global TEN Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global TEN Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas TEN Treatment Sales Growth
4.4 APAC TEN Treatment Sales Growth
4.5 Europe TEN Treatment Sales Growth
4.6 Middle East & Africa TEN Treatment Sales Growth
5 Americas
5.1 Americas TEN Treatment Sales by Country
5.1.1 Americas TEN Treatment Sales by Country (2018-2023)
5.1.2 Americas TEN Treatment Revenue by Country (2018-2023)
5.2 Americas TEN Treatment Sales by Type
5.3 Americas TEN Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TEN Treatment Sales by Region
6.1.1 APAC TEN Treatment Sales by Region (2018-2023)
6.1.2 APAC TEN Treatment Revenue by Region (2018-2023)
6.2 APAC TEN Treatment Sales by Type
6.3 APAC TEN Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe TEN Treatment by Country
7.1.1 Europe TEN Treatment Sales by Country (2018-2023)
7.1.2 Europe TEN Treatment Revenue by Country (2018-2023)
7.2 Europe TEN Treatment Sales by Type
7.3 Europe TEN Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa TEN Treatment by Country
8.1.1 Middle East & Africa TEN Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa TEN Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa TEN Treatment Sales by Type
8.3 Middle East & Africa TEN Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of TEN Treatment
10.3 Manufacturing Process Analysis of TEN Treatment
10.4 Industry Chain Structure of TEN Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 TEN Treatment Distributors
11.3 TEN Treatment Customer
12 World Forecast Review for TEN Treatment by Geographic Region
12.1 Global TEN Treatment Market Size Forecast by Region
12.1.1 Global TEN Treatment Forecast by Region (2024-2029)
12.1.2 Global TEN Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global TEN Treatment Forecast by Type
12.7 Global TEN Treatment Forecast by Application
13 Key Players Analysis
13.1 3M
13.1.1 3M Company Information
13.1.2 3M TEN Treatment Product Portfolios and Specifications
13.1.3 3M TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 Cardinal Health
13.2.1 Cardinal Health Company Information
13.2.2 Cardinal Health TEN Treatment Product Portfolios and Specifications
13.2.3 Cardinal Health TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Cardinal Health Main Business Overview
13.2.5 Cardinal Health Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD TEN Treatment Product Portfolios and Specifications
13.3.3 BD TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Smith + Nephew
13.4.1 Smith + Nephew Company Information
13.4.2 Smith + Nephew TEN Treatment Product Portfolios and Specifications
13.4.3 Smith + Nephew TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Smith + Nephew Main Business Overview
13.4.5 Smith + Nephew Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG TEN Treatment Product Portfolios and Specifications
13.5.3 Novartis AG TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Amneal Pharmaceuticals LLC.
13.6.1 Amneal Pharmaceuticals LLC. Company Information
13.6.2 Amneal Pharmaceuticals LLC. TEN Treatment Product Portfolios and Specifications
13.6.3 Amneal Pharmaceuticals LLC. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Amneal Pharmaceuticals LLC. Main Business Overview
13.6.5 Amneal Pharmaceuticals LLC. Latest Developments
13.7 Amgen Inc.
13.7.1 Amgen Inc. Company Information
13.7.2 Amgen Inc. TEN Treatment Product Portfolios and Specifications
13.7.3 Amgen Inc. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Amgen Inc. Main Business Overview
13.7.5 Amgen Inc. Latest Developments
13.8 Pfizer Inc.
13.8.1 Pfizer Inc. Company Information
13.8.2 Pfizer Inc. TEN Treatment Product Portfolios and Specifications
13.8.3 Pfizer Inc. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pfizer Inc. Main Business Overview
13.8.5 Pfizer Inc. Latest Developments
13.9 Colgate-Palmolive Company
13.9.1 Colgate-Palmolive Company Company Information
13.9.2 Colgate-Palmolive Company TEN Treatment Product Portfolios and Specifications
13.9.3 Colgate-Palmolive Company TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Colgate-Palmolive Company Main Business Overview
13.9.5 Colgate-Palmolive Company Latest Developments
13.10 Merck & Co., Inc.
13.10.1 Merck & Co., Inc. Company Information
13.10.2 Merck & Co., Inc. TEN Treatment Product Portfolios and Specifications
13.10.3 Merck & Co., Inc. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Merck & Co., Inc. Main Business Overview
13.10.5 Merck & Co., Inc. Latest Developments
13.11 Molnlycke HealthCare AB.
13.11.1 Molnlycke HealthCare AB. Company Information
13.11.2 Molnlycke HealthCare AB. TEN Treatment Product Portfolios and Specifications
13.11.3 Molnlycke HealthCare AB. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Molnlycke HealthCare AB. Main Business Overview
13.11.5 Molnlycke HealthCare AB. Latest Developments
13.12 Xttrium Laboratories
13.12.1 Xttrium Laboratories Company Information
13.12.2 Xttrium Laboratories TEN Treatment Product Portfolios and Specifications
13.12.3 Xttrium Laboratories TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Xttrium Laboratories Main Business Overview
13.12.5 Xttrium Laboratories Latest Developments
13.13 Schulke & Mayr GmbH
13.13.1 Schulke & Mayr GmbH Company Information
13.13.2 Schulke & Mayr GmbH TEN Treatment Product Portfolios and Specifications
13.13.3 Schulke & Mayr GmbH TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Schulke & Mayr GmbH Main Business Overview
13.13.5 Schulke & Mayr GmbH Latest Developments
13.14 ICPA Health Products Ltd
13.14.1 ICPA Health Products Ltd Company Information
13.14.2 ICPA Health Products Ltd TEN Treatment Product Portfolios and Specifications
13.14.3 ICPA Health Products Ltd TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 ICPA Health Products Ltd Main Business Overview
13.14.5 ICPA Health Products Ltd Latest Developments
13.15 Purdue Pharma L.P.
13.15.1 Purdue Pharma L.P. Company Information
13.15.2 Purdue Pharma L.P. TEN Treatment Product Portfolios and Specifications
13.15.3 Purdue Pharma L.P. TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Purdue Pharma L.P. Main Business Overview
13.15.5 Purdue Pharma L.P. Latest Developments
13.16 eugia (Subsidiary of Aurobindo Pharma)
13.16.1 eugia (Subsidiary of Aurobindo Pharma) Company Information
13.16.2 eugia (Subsidiary of Aurobindo Pharma) TEN Treatment Product Portfolios and Specifications
13.16.3 eugia (Subsidiary of Aurobindo Pharma) TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 eugia (Subsidiary of Aurobindo Pharma) Main Business Overview
13.16.5 eugia (Subsidiary of Aurobindo Pharma) Latest Developments
13.17 AdvaCare Pharma
13.17.1 AdvaCare Pharma Company Information
13.17.2 AdvaCare Pharma TEN Treatment Product Portfolios and Specifications
13.17.3 AdvaCare Pharma TEN Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 AdvaCare Pharma Main Business Overview
13.17.5 AdvaCare Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. TEN Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. TEN Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral Type
Table 4. Major Players of External Type
Table 5. Major Players of Other
Table 6. Global TEN Treatment Sales by Type (2018-2023) & (K Units)
Table 7. Global TEN Treatment Sales Market Share by Type (2018-2023)
Table 8. Global TEN Treatment Revenue by Type (2018-2023) & ($ million)
Table 9. Global TEN Treatment Revenue Market Share by Type (2018-2023)
Table 10. Global TEN Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global TEN Treatment Sales by Application (2018-2023) & (K Units)
Table 12. Global TEN Treatment Sales Market Share by Application (2018-2023)
Table 13. Global TEN Treatment Revenue by Application (2018-2023)
Table 14. Global TEN Treatment Revenue Market Share by Application (2018-2023)
Table 15. Global TEN Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global TEN Treatment Sales by Company (2018-2023) & (K Units)
Table 17. Global TEN Treatment Sales Market Share by Company (2018-2023)
Table 18. Global TEN Treatment Revenue by Company (2018-2023) ($ Millions)
Table 19. Global TEN Treatment Revenue Market Share by Company (2018-2023)
Table 20. Global TEN Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers TEN Treatment Producing Area Distribution and Sales Area
Table 22. Players TEN Treatment Products Offered
Table 23. TEN Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global TEN Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global TEN Treatment Sales Market Share Geographic Region (2018-2023)
Table 28. Global TEN Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global TEN Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global TEN Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global TEN Treatment Sales Market Share by Country/Region (2018-2023)
Table 32. Global TEN Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global TEN Treatment Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas TEN Treatment Sales by Country (2018-2023) & (K Units)
Table 35. Americas TEN Treatment Sales Market Share by Country (2018-2023)
Table 36. Americas TEN Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas TEN Treatment Revenue Market Share by Country (2018-2023)
Table 38. Americas TEN Treatment Sales by Type (2018-2023) & (K Units)
Table 39. Americas TEN Treatment Sales by Application (2018-2023) & (K Units)
Table 40. APAC TEN Treatment Sales by Region (2018-2023) & (K Units)
Table 41. APAC TEN Treatment Sales Market Share by Region (2018-2023)
Table 42. APAC TEN Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC TEN Treatment Revenue Market Share by Region (2018-2023)
Table 44. APAC TEN Treatment Sales by Type (2018-2023) & (K Units)
Table 45. APAC TEN Treatment Sales by Application (2018-2023) & (K Units)
Table 46. Europe TEN Treatment Sales by Country (2018-2023) & (K Units)
Table 47. Europe TEN Treatment Sales Market Share by Country (2018-2023)
Table 48. Europe TEN Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe TEN Treatment Revenue Market Share by Country (2018-2023)
Table 50. Europe TEN Treatment Sales by Type (2018-2023) & (K Units)
Table 51. Europe TEN Treatment Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa TEN Treatment Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa TEN Treatment Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa TEN Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa TEN Treatment Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa TEN Treatment Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa TEN Treatment Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of TEN Treatment
Table 59. Key Market Challenges & Risks of TEN Treatment
Table 60. Key Industry Trends of TEN Treatment
Table 61. TEN Treatment Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. TEN Treatment Distributors List
Table 64. TEN Treatment Customer List
Table 65. Global TEN Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global TEN Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas TEN Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas TEN Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC TEN Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC TEN Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe TEN Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe TEN Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa TEN Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa TEN Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global TEN Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global TEN Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global TEN Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global TEN Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. 3M Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 80. 3M TEN Treatment Product Portfolios and Specifications
Table 81. 3M TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. 3M Main Business
Table 83. 3M Latest Developments
Table 84. Cardinal Health Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 85. Cardinal Health TEN Treatment Product Portfolios and Specifications
Table 86. Cardinal Health TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. Cardinal Health Main Business
Table 88. Cardinal Health Latest Developments
Table 89. BD Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 90. BD TEN Treatment Product Portfolios and Specifications
Table 91. BD TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. BD Main Business
Table 93. BD Latest Developments
Table 94. Smith + Nephew Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 95. Smith + Nephew TEN Treatment Product Portfolios and Specifications
Table 96. Smith + Nephew TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Smith + Nephew Main Business
Table 98. Smith + Nephew Latest Developments
Table 99. Novartis AG Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 100. Novartis AG TEN Treatment Product Portfolios and Specifications
Table 101. Novartis AG TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. Novartis AG Main Business
Table 103. Novartis AG Latest Developments
Table 104. Amneal Pharmaceuticals LLC. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 105. Amneal Pharmaceuticals LLC. TEN Treatment Product Portfolios and Specifications
Table 106. Amneal Pharmaceuticals LLC. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. Amneal Pharmaceuticals LLC. Main Business
Table 108. Amneal Pharmaceuticals LLC. Latest Developments
Table 109. Amgen Inc. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 110. Amgen Inc. TEN Treatment Product Portfolios and Specifications
Table 111. Amgen Inc. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Amgen Inc. Main Business
Table 113. Amgen Inc. Latest Developments
Table 114. Pfizer Inc. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 115. Pfizer Inc. TEN Treatment Product Portfolios and Specifications
Table 116. Pfizer Inc. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Pfizer Inc. Main Business
Table 118. Pfizer Inc. Latest Developments
Table 119. Colgate-Palmolive Company Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 120. Colgate-Palmolive Company TEN Treatment Product Portfolios and Specifications
Table 121. Colgate-Palmolive Company TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Colgate-Palmolive Company Main Business
Table 123. Colgate-Palmolive Company Latest Developments
Table 124. Merck & Co., Inc. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 125. Merck & Co., Inc. TEN Treatment Product Portfolios and Specifications
Table 126. Merck & Co., Inc. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. Merck & Co., Inc. Main Business
Table 128. Merck & Co., Inc. Latest Developments
Table 129. Molnlycke HealthCare AB. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 130. Molnlycke HealthCare AB. TEN Treatment Product Portfolios and Specifications
Table 131. Molnlycke HealthCare AB. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Molnlycke HealthCare AB. Main Business
Table 133. Molnlycke HealthCare AB. Latest Developments
Table 134. Xttrium Laboratories Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 135. Xttrium Laboratories TEN Treatment Product Portfolios and Specifications
Table 136. Xttrium Laboratories TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. Xttrium Laboratories Main Business
Table 138. Xttrium Laboratories Latest Developments
Table 139. Schulke & Mayr GmbH Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 140. Schulke & Mayr GmbH TEN Treatment Product Portfolios and Specifications
Table 141. Schulke & Mayr GmbH TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Schulke & Mayr GmbH Main Business
Table 143. Schulke & Mayr GmbH Latest Developments
Table 144. ICPA Health Products Ltd Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 145. ICPA Health Products Ltd TEN Treatment Product Portfolios and Specifications
Table 146. ICPA Health Products Ltd TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. ICPA Health Products Ltd Main Business
Table 148. ICPA Health Products Ltd Latest Developments
Table 149. Purdue Pharma L.P. Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 150. Purdue Pharma L.P. TEN Treatment Product Portfolios and Specifications
Table 151. Purdue Pharma L.P. TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Purdue Pharma L.P. Main Business
Table 153. Purdue Pharma L.P. Latest Developments
Table 154. eugia (Subsidiary of Aurobindo Pharma) Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 155. eugia (Subsidiary of Aurobindo Pharma) TEN Treatment Product Portfolios and Specifications
Table 156. eugia (Subsidiary of Aurobindo Pharma) TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. eugia (Subsidiary of Aurobindo Pharma) Main Business
Table 158. eugia (Subsidiary of Aurobindo Pharma) Latest Developments
Table 159. AdvaCare Pharma Basic Information, TEN Treatment Manufacturing Base, Sales Area and Its Competitors
Table 160. AdvaCare Pharma TEN Treatment Product Portfolios and Specifications
Table 161. AdvaCare Pharma TEN Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. AdvaCare Pharma Main Business
Table 163. AdvaCare Pharma Latest Developments
List of Figures
Figure 1. Picture of TEN Treatment
Figure 2. TEN Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global TEN Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global TEN Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. TEN Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral Type
Figure 10. Product Picture of External Type
Figure 11. Product Picture of Other
Figure 12. Global TEN Treatment Sales Market Share by Type in 2022
Figure 13. Global TEN Treatment Revenue Market Share by Type (2018-2023)
Figure 14. TEN Treatment Consumed in Child
Figure 15. Global TEN Treatment Market: Child (2018-2023) & (K Units)
Figure 16. TEN Treatment Consumed in Aldult
Figure 17. Global TEN Treatment Market: Aldult (2018-2023) & (K Units)
Figure 18. Global TEN Treatment Sales Market Share by Application (2022)
Figure 19. Global TEN Treatment Revenue Market Share by Application in 2022
Figure 20. TEN Treatment Sales Market by Company in 2022 (K Units)
Figure 21. Global TEN Treatment Sales Market Share by Company in 2022
Figure 22. TEN Treatment Revenue Market by Company in 2022 ($ Million)
Figure 23. Global TEN Treatment Revenue Market Share by Company in 2022
Figure 24. Global TEN Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global TEN Treatment Revenue Market Share by Geographic Region in 2022
Figure 26. Americas TEN Treatment Sales 2018-2023 (K Units)
Figure 27. Americas TEN Treatment Revenue 2018-2023 ($ Millions)
Figure 28. APAC TEN Treatment Sales 2018-2023 (K Units)
Figure 29. APAC TEN Treatment Revenue 2018-2023 ($ Millions)
Figure 30. Europe TEN Treatment Sales 2018-2023 (K Units)
Figure 31. Europe TEN Treatment Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa TEN Treatment Sales 2018-2023 (K Units)
Figure 33. Middle East & Africa TEN Treatment Revenue 2018-2023 ($ Millions)
Figure 34. Americas TEN Treatment Sales Market Share by Country in 2022
Figure 35. Americas TEN Treatment Revenue Market Share by Country in 2022
Figure 36. Americas TEN Treatment Sales Market Share by Type (2018-2023)
Figure 37. Americas TEN Treatment Sales Market Share by Application (2018-2023)
Figure 38. United States TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC TEN Treatment Sales Market Share by Region in 2022
Figure 43. APAC TEN Treatment Revenue Market Share by Regions in 2022
Figure 44. APAC TEN Treatment Sales Market Share by Type (2018-2023)
Figure 45. APAC TEN Treatment Sales Market Share by Application (2018-2023)
Figure 46. China TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. India TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe TEN Treatment Sales Market Share by Country in 2022
Figure 54. Europe TEN Treatment Revenue Market Share by Country in 2022
Figure 55. Europe TEN Treatment Sales Market Share by Type (2018-2023)
Figure 56. Europe TEN Treatment Sales Market Share by Application (2018-2023)
Figure 57. Germany TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 58. France TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa TEN Treatment Sales Market Share by Country in 2022
Figure 63. Middle East & Africa TEN Treatment Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa TEN Treatment Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa TEN Treatment Sales Market Share by Application (2018-2023)
Figure 66. Egypt TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country TEN Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of TEN Treatment in 2022
Figure 72. Manufacturing Process Analysis of TEN Treatment
Figure 73. Industry Chain Structure of TEN Treatment
Figure 74. Channels of Distribution
Figure 75. Global TEN Treatment Sales Market Forecast by Region (2024-2029)
Figure 76. Global TEN Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global TEN Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global TEN Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global TEN Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global TEN Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のTEN治療市場予測 2023年-2029年] (コード：LP23DC09600)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のTEN治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の肢先端脳梁症候群治療市場予測 2023年-2029年
  • 世界の血管性認知症治療市場予測 2023年-2029年
  • 世界の膜性腎症治療市場予測 2023年-2029年
  • 世界の副甲状腺疾患治療市場予測 2023年-2029年
  • 世界の成人非ホジキンリンパ腫治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆